BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 37004588)

  • 1. Repositioning of Benzodiazepine Drugs and Synergistic Effect with Ciprofloxacin Against ESKAPE Pathogens.
    da Rosa TF; Serafin MB; Foletto VS; Franco LN; de Paula BR; Fuchs LB; Calegari L; Hörner R
    Curr Microbiol; 2023 Apr; 80(5):160. PubMed ID: 37004588
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Repositioning of antidepressant drugs and synergistic effect with ciprofloxacin against multidrug-resistant bacteria.
    Foletto VS; da Rosa TF; Serafin MB; Bottega A; Franco LN; de Paula BR; Hörner R
    World J Microbiol Biotechnol; 2021 Feb; 37(3):53. PubMed ID: 33604693
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Repurposing of escitalopram oxalate and clonazepam in combination with ciprofloxacin and sulfamethoxazole-trimethoprim for treatment of multidrug-resistant microorganisms and evaluation of the cleavage capacity of plasmid DNA.
    Rosa TFD; Machado CS; Serafin MB; Bottega A; Coelho SS; Foletto VS; Rampelotto RF; Lorenzoni VV; Mainardi A; Hörner R
    Can J Microbiol; 2021 Aug; 67(8):599-612. PubMed ID: 33481681
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Norfloxacin salts of carboxylic acids curtail planktonic and biofilm mode of growth in ESKAPE pathogens.
    Lowrence RC; Ramakrishnan A; Sundaramoorthy NS; Shyam A; Mohan V; Subbarao HMV; Ulaganathan V; Raman T; Solomon A; Nagarajan S
    J Appl Microbiol; 2018 Feb; 124(2):408-422. PubMed ID: 29178633
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterisation of ESKAPE Pathogens with Special Reference to Multidrug Resistance and Biofilm Production in a Nepalese Hospital.
    Pandey R; Mishra SK; Shrestha A
    Infect Drug Resist; 2021; 14():2201-2212. PubMed ID: 34163185
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alternatives for the treatment of infections caused by ESKAPE pathogens.
    da Rosa TF; Coelho SS; Foletto VS; Bottega A; Serafin MB; Machado CS; Franco LN; de Paula BR; Hörner R
    J Clin Pharm Ther; 2020 Aug; 45(4):863-873. PubMed ID: 32339305
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Polyhexamethylene guanidine hydrochloride shows bactericidal advantages over chlorhexidine digluconate against ESKAPE bacteria.
    Zhou Z; Wei D; Lu Y
    Biotechnol Appl Biochem; 2015; 62(2):268-74. PubMed ID: 24888899
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Functional Differences between E. coli and ESKAPE Pathogen GroES/GroEL.
    Sivinski J; Ambrose AJ; Panfilenko I; Zerio CJ; Machulis JM; Mollasalehi N; Kaneko LK; Stevens M; Ray AM; Park Y; Wu C; Hoang QQ; Johnson SM; Chapman E
    mBio; 2021 Jan; 12(1):. PubMed ID: 33436430
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibacterial activity of traditional spices against lower respiratory tract pathogens: combinatorial effects of Trachyspermum ammi essential oil with conventional antibiotics.
    Grădinaru AC; Trifan A; Şpac A; Brebu M; Miron A; Aprotosoaie AC
    Lett Appl Microbiol; 2018 Nov; 67(5):449-457. PubMed ID: 30187508
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bactericidal efficacy of atmospheric pressure non-thermal plasma (APNTP) against the ESKAPE pathogens.
    Flynn PB; Higginbotham S; Alshraiedeh NH; Gorman SP; Graham WG; Gilmore BF
    Int J Antimicrob Agents; 2015 Jul; 46(1):101-7. PubMed ID: 25963338
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human Salivary Protein Histatin 5 Has Potent Bactericidal Activity against ESKAPE Pathogens.
    Du H; Puri S; McCall A; Norris HL; Russo T; Edgerton M
    Front Cell Infect Microbiol; 2017; 7():41. PubMed ID: 28261570
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Repurposing Non-Antimicrobial Drugs and Clinical Molecules to Treat Bacterial Infections.
    Younis W; Thangamani S; Seleem MN
    Curr Pharm Des; 2015; 21(28):4106-11. PubMed ID: 25961308
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antimicrobial and Antibiofilm Activity of Lys-[Trp6]hy-a1 Combined with Ciprofloxacin Against Gram-Negative Bacteria.
    Carneiro VA; de Oliveira ST; Silva RL; de Sousa Duarte H; Silva ML; Matos MNC; Cavalcante RMB; Figueira CS; Lorenzón EN; Cilli EM; da Cunha RMS
    Protein Pept Lett; 2020; 27(11):1124-1131. PubMed ID: 32297570
    [TBL] [Abstract][Full Text] [Related]  

  • 14. From Breast Cancer to Antimicrobial: Combating Extremely Resistant Gram-Negative "Superbugs" Using Novel Combinations of Polymyxin B with Selective Estrogen Receptor Modulators.
    Hussein MH; Schneider EK; Elliott AG; Han M; Reyes-Ortega F; Morris F; Blastovich MAT; Jasim R; Currie B; Mayo M; Baker M; Cooper MA; Li J; Velkov T
    Microb Drug Resist; 2017 Jul; 23(5):640-650. PubMed ID: 27935770
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antarctic Marine Bacteria as a Source of Anti-Biofilm Molecules to Combat ESKAPE Pathogens.
    Artini M; Papa R; Vrenna G; Trecca M; Paris I; D'Angelo C; Tutino ML; Parrilli E; Selan L
    Antibiotics (Basel); 2023 Oct; 12(10):. PubMed ID: 37887257
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Kisameet Clay Exhibits Potent Antibacterial Activity against the ESKAPE Pathogens.
    Behroozian S; Svensson SL; Davies J
    mBio; 2016 Jan; 7(1):e01842-15. PubMed ID: 26814180
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antimicrobial susceptibility of Gram-negative ESKAPE pathogens isolated from hospitalized patients with intra-abdominal and urinary tract infections in Asia-Pacific countries: SMART 2013-2015.
    Karlowsky JA; Hoban DJ; Hackel MA; Lob SH; Sahm DF
    J Med Microbiol; 2017 Jan; 66(1):61-69. PubMed ID: 28051952
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ventilator-associated pneumonia caused by ESKAPE organisms: cause, clinical features, and management.
    Sandiumenge A; Rello J
    Curr Opin Pulm Med; 2012 May; 18(3):187-93. PubMed ID: 22366995
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Current scenario of quinolone hybrids with potential antibacterial activity against ESKAPE pathogens.
    Gao J; Hou H; Gao F
    Eur J Med Chem; 2023 Feb; 247():115026. PubMed ID: 36577217
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibiotic resistance of ESKAPE group-microorganisms in health institutions from Hermosillo and Ciudad Obregón, Sonora, México.
    Álvarez-Ainza ML; Fong-Coronado PA; Ruiz-Bustos E; Castillón-Campaña LG; Quintero-Reyes IE; Duarte-Zambrano LA; Bolado-Martínez E
    Front Cell Infect Microbiol; 2024; 14():1348093. PubMed ID: 38516533
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.